Prevention of tunneled cuffed catheter dysfunction with prophylactic use of a taurolidine urokinase lock: A randomized double-blind trial.
<h4>Background</h4>The efficacy and cost-effectiveness of prophylactic thrombolytic locks in hemodialysis patients at high-risk of thrombotic dialysis catheter dysfunction is uncertain. We investigated this question in a double-blinded randomized controlled study.<h4>Methods</h4...
        Enregistré dans:
      
    
                  | Auteurs principaux: | Florence Bonkain, Jean-Claude Stolear, Concetta Catalano, Dominique Vandervelde, Serge Treille, Marie M Couttenye, Annemieke Dhondt, Mark Libertalis, Mandelina Allamani, Philippe Madhoun, Amaryllis H Van Craenenbroeck, Floris Vanommeslaeghe, Freya Van Hulle, Philippe Durieux, Ingrid Van Limberghen, Christian Tielemans, Karl Martin Wissing | 
|---|---|
| Format: | article | 
| Langue: | EN | 
| Publié: | 
        
      Public Library of Science (PLoS)    
    
      2021
     | 
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/874c58bd249d4dae8b2a65bec877f305 | 
| Tags: | 
       Ajouter un tag    
     
      Pas de tags, Soyez le premier à ajouter un tag!
   
 | 
Documents similaires
- 
                
        
          Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall.        
                  
par: Francesco Caruso, et autres
Publié: (2010) - 
                
        
          Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials.        
                  
par: Yong Liu, et autres
Publié: (2013) - 
                
        
          Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas        
                  
par: Maria Vincenza Carriero, et autres
Publié: (2017) - 
                
        
          Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator        
                  
par: Tobias Kromann-Hansen, et autres
Publié: (2017) - 
                
        
          Soluble urokinase plasminogen activator receptor as a marker for use of antidepressants.        
                  
par: Eva Haastrup, et autres
Publié: (2014)